Live Breaking News & Updates on Effector Therapeutics Inc

Stay updated with breaking news from Effector therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

eFFECTOR Therapeutics (NASDAQ:EFTR) Trading Up 2.4%

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTR – Get Free Report)’s stock price traded up 2.4% during mid-day trading on Thursday . The company traded as high as $1.73 and last traded at $1.70. 40,296 shares were traded during trading, a decline of 85% from the average session volume of 275,058 shares. The stock had previously closed at […] ....

Securities Exchange Commission , Effector Therapeutics Inc , Get Free Report , Point Capital , Free Report ,

EFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 eFFECTOR Therapeutics, Inc. , a leader in the development of selective translation regulator inhibitors for the treatment of cancer,. ....

United States , Panagiotis Konstantinopoulos , Michael Fitzhugh , Christopherm Calabrese , Kevin Gardner , Doug Warner , Lifesci Communications , Professor Of Medicine At Harvard Medical School , Dana Farber Cancer Institute , Exchange Commission , Effector Therapeutics Inc , Translational Research , Division Of Gynecologic Oncology , Gynecologic Oncology , Associate Professor , Harvard Medical , Private Securities Litigation Reform Act ,

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Doug Warner , Michael Fitzhugh , Panagiotis Konstantinopoulos , Kevin Gardner , Christopherm Calabrese , Effector Therapeutics Inc , Lifesci Communications , Exchange Commission , Division Of Gynecologic Oncology , Translational Research , Dana Farber Cancer Institute , Professor Of Medicine At Harvard Medical School , Investigator Sponsored Phase , Trial Evaluating Zotatifin , Combination Treatment , Endometrial Cancer , Low Grade Serous Ovarian , Gynecologic Oncology , Associate Professor , Harvard Medical , Private Securities Litigation Reform Act ,

EFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

EFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Jennifer Caswell Jin , Christopherm Calabrese , Christian Curtis , Kevin Gardner , Mike Tattory , Steve Worland , Exchange Commission , Northwestern University , Roberth Lurie Comprehensive Cancer Center , Lifesci Communications , Development Rd Expenses , Effector Therapeutics Inc , Antonio Breast Cancer Symposium , Stanford Medicine , Assistant Professor , Biomedical Data Science , Artificial Intelligence , Cancer Genomics , Acute Myeloid Leukemia , Shira Dinner , Associate Professor , Comprehensive Cancer Center , Private Securities Litigation Reform Act , Consolidated Statement , Months Ended March ,

eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Kevin Gardner , Christian Curtis , Christopherm Calabrese , Jennifer Caswell Jin , Steve Worland , Mike Tattory , Northwestern University , Effector Therapeutics Inc , Development Rd Expenses , Roberth Lurie Comprehensive Cancer Center , Exchange Commission , Lifesci Communications , Reports First Quarter , Provides Corporate , Antonio Breast Cancer Symposium , Stanford Medicine , Assistant Professor , Biomedical Data Science , Artificial Intelligence , Cancer Genomics , Acute Myeloid Leukemia , Shira Dinner , Associate Professor , Comprehensive Cancer Center , Private Securities Litigation Reform Act ,